Giovanni Fucà

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock et al. · JNCI Journal of the National Cancer Institute · 2017 · 322 citations · Full text

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti et al. · British Journal of Cancer · 2020 · 315 citations · Full text

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

Giovanni Fucà, Giulia Galli, M. Poggi et al. · ESMO Open · 2019 · 203 citations · Full text

Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors

Koichi Hirabayashi, Hongwei Du, Yang Xu et al. · Nature Cancer · 2021 · 192 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +8

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case–control study

Chiara Cremolini, Federica Morano, Roberto Moretto et al. · Annals of Oncology · 2017 · 116 citations · Full text

Anti-egfr Monoclonal Antibodies, Medicine, Immunology +8